At Banner Life Sciences, we combine formulation expertise with proprietary technologies to create specialty pharmaceuticals that help patients with unmet clinical needs.

  • ABOUT BANNER LIFE SCIENCES

    Innovation is core to our process, from identifying those unmet health needs to developing different ways to apply formulation technologies to create new medicines and enhance existing products.

    Learn more here.

  • LEARN MORE ABOUT BAFIERTAM

    BAFIERTAM® (monomethyl fumarate) is a disease-modifying therapy (DMT) for the treatment of relapsing forms of MS. DMTs are not a cure for relapsing forms of MS. But they can help reduce the number of relapses and decrease the clinical disability progression.

    Learn more here.

  • CONTACT BANNER LIFE SCIENCES

NEWS & UPDATES

  • Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for Multiple Sclerosis

    April 30, 2020